Gilead Sciences

Vertex Pharmaceuticals

Amgen

Regeneron Pharmaceuticals

IQVIA Hlds

Alnylam Pharmaceuticals

Mettler-Toledo

Biogen

Illumina

Waters

iShares Nasdaq Biotechnology ETF

IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.

VanEck Vectors Semiconductor ETF

Those of you who are new to the Daily, you probably noticed the references to the Economic Modern Family. Mish developed one index and five sectors as the nucleus of the Family to help you and herself see the real economy as portrayed through a combination of cyclicals and non cyclicals.

Can Tech and Biotech Continue to Break New Highs?

VanEck Vectors Biotech ETF

SPDR S&P Biotech ETF

November has been a big month for stock and biotech ETFs, and with the Federal Aviation Administration announcing that it supported the “first mass air shipment” of coronavirus vaccines on Friday, pharmaceutical companies and airlines are now readying networks for wide dissemination, which could be a further boon for biotech ETFs. United Airlines ferried Pfizer's much-touted [.

How Will Vaccine Arrivals Affect Biotech ETFs?

Invesco Dynamic Biotechnology & Genome ETF

Biotech stocks are likely to remain in focus through year end amid news surrounding COVID-19 vaccines and treatments.

2 Biotech Funds Poised for a Healthy Breakout

Loncar Cancer Immunotherapy ETF

Healthcare stocks and ETFs are continuing to outperform as investors are optimistic about an upcoming vaccine for the coronavirus, which has been a blight on the globe since early this year. There has been some debate as to exactly when the vaccines will be available however.

Biotech ETFs Remain Hot As Investors Await Upcoming Vaccine

First Trust NASDAQ Global Auto Index Fund

First Trust NYSE Arca Biotechnology Index Fund

US Global Jets ETF

Invesco KBW Bank ETF

SPDR S&P Regional Banking ETF

Invesco Dynamic Leisure and Entertainment ETF

SPDR S&P Oil & Gas Equipment & Services ETF

Energy Select Sector SPDR Fund

The introduction of the coronavirus vaccine is expected to help in the economic recovery, especially for sectors which have taken a hit from the social-distancing and lockdown measures.

ETF Sectors to Bet on Positive Vaccine News

Biotech ETFs are getting a boost along with stocks on Monday thanks to Moderna, which announced that its initial phase three trial data reveals a coronavirus vaccine that is over 94% effective. Shares of the Moderna surged over 12% in premarket trading, and are still up over 7.5%.

Biotech ETFs Poised for Gains after Moderna Vaccine News

Monday saw stocks and index ETFs surge, after the announcement from Pfizer that the pharmaceutical giant had a vaccine candidate with an over 90% effectiveness in clinical trials. Now another biotech, Moderna, is anticipated to release key data shortly from a late-stage trial, that will reveal whether its Covid-19 vaccine is efficacious.

Will Moderna Vaccine News Boost Biotech ETFs?

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

Vanguard Health Care ETF

Health Care Select Sector SPDR Fund

Easing worries regarding major policy changes are driving the relief rally in the healthcare and biotech spaces in the post-election period.

Here's Why Healthcare ETFs Are Rallying Post Elections

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their third-quarter earnings releases amid the coronavirus crisis.

How Will Biotech ETFs React to These Q3 Earnings Release?

DexCom

IDEXX Laboratories

Moderna

Pfizer

QuidelOrtho Corp

If you're interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip. The post Which Biotech Stocks Are a Buy on Earnings?

Which Biotech Stocks Are a Buy on Earnings?

iShares Genomics Immunology and Healthcare ETF

The election year and the coronavirus has highlighted the importance of an adaptive health industry that meets up with quickly changing times. Investors can also tap into this evolution in healthcare through targeted exchange traded fund strategies to capture this shifting opportunity.

ETF Strategies to Tap into Medical Breakthroughs, Healthcare Innovations

Biotechnology exchange-traded funds outperformed Tuesday as investors focused on next-generation solutions to the coronavirus and more. The ARK Genomic Revolution ETF was up 2.2% in the early afternoon, on track for its biggest daily gain in nearly three weeks.

Biotech ETFs at multi-week highs, extending winning streak

iShares Russell 2000 ETF

iShares Transportation Average ETF

SPDR S&P Retail ETF

In spite of no passing government stimulus, mixed economic data, rising covid cases and a wild pre election season, for the first time since we can remember, our core stock market ETFs are brushing off most of the negativity.

These 6 Stock Market ETFs Are Cheering On The Bull Market

CRISPR Therapeutics

Regardless of lockdowns or otherwise, these biotech stocks are positioned to rally strongly in the weeks and months ahead The post 3 Biotech Stocks to Buy Right Now appeared first on InvestorPlace. More From InvestorPlace Forget The Election… Pick These Stocks for the Win in 2021 Why Everyone Is Investing in 5G All WRONG America's #1 Stock Picker Reveals His Next 1,000% Winner Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company

3 Biotech Stocks to Buy Right Now

Vertex Pharmaceuticals (VRTX) sold off on heavy volume after discontinuing trials of a promising liver disease treatment.

Vertex (VRTX) Drops 20% After Failed Drug Trial

ARK Genomic Revolution Multi-Sector ETF

With Regeneron Pharmaceuticals and Eli Lilly & Company requesting the FDA for an Emergency Use Authorization for their antibody therapy treatments, the biotech space is filled with optimism.

Biotech ETFs to Shine on Coronavirus Antibodies Progress

VanEck Video Gaming and eSports ETF

Amplify Online Retail ETF

iShares Global Clean Energy ETF

Vanguard Information Technology ETF

Here we discuss ETFs that can be a good addition for enhanced portfolio returns in the fourth quarter of 2020.

5 ETFs That Make Attractive Investment Choices in Q4

The race to introduce vaccine and treatment of coronavirus is opening up opportunities, making the biotech sector a prospective space for investments.

Top-Performing Biotech ETFs Amid the Coronavirus Crisis

Johnson & Johnson's entry into the late-stage trials has increased optimism in the coronavirus vaccine development.

Biotech ETFs in Focus as the COVID-19 Vaccine Race Intensifies

With companies like Pfizer (PFE) giving possible hope for an end of year vaccine and a recent gap up in Nasdaq Biotechnology ETF (IBB), now could be a good time to keep an eye on newer issues in this sector. Large amounts of buying came into IBB Friday.

Recent Buying In Biotech Sector Could Benefit Newer Companies

Ironwood Pharma

The novel coronavirus is weighing on the market, but these four biotech stocks can survive. Here's what you need to know to profit now.

4 Biotech Stocks to Buy for Big Gains in 2020

Roundhill Sports Betting & iGaming ETF

Global X Telemedicine & Digital Health ETF

iShares U.S. Medical Devices ETF

Direxion Work From Home ETF

Global X's new telemedicine fund proves to be the right ETF for the right moment.

Sleeper Hit ETF Of 2020

Nine vaccine developers have jointly pledged to observe high ethical standards in conducting clinical studies and manufacturing of vaccines.

How Will Biotech ETFs React to Vaccine Makers' Safety Pledge?

ProShares Short Dow30

ProShares UltraShort Dow30

Vanguard Consumer Discretionary ETF

Vanguard Dividend Appreciation ETF

Vanguard Industrials ETF

Vanguard High Dividend Yield ETF

Consumer Discretionary Select Sector SPDR Fund

Let's look at some ETF areas one can consider investing in for a smooth sail amid the turbulences September can usher in.

ETF Areas to Consider This Cursed September Amid Coronavirus

This company is riding a powerful trend in the future of healthcare. Plus, it offers high growth, a huge potential market and a path to profitability.

News for iShares Nasdaq Biotechnology ETF ETF (IBB)